Navigation Links
J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
Date:11/12/2008

Venter Shares Award with James D. Watson, Marilyn & James Simons and Sherry Lansing at Gala New York City Event

ROCKVILLE, Md., Nov. 12 /PRNewswire-USNewswire/ -- J. Craig Venter, Ph.D., Founder and President of the J. Craig Venter Institute (JCVI), was awarded the Double Helix Medal from Cold Spring Harbor Laboratory (CSHL) on November 6th at a gala event in New York City.

Dr. Venter received the Double Helix Medal along with Dr. James D. Watson for making each of their individual genome sequences available for scientific use on the Internet and for promoting awareness of the public health advantages of "personalized genomes."

According to Dr. Bruce Stillman, CSHL President, "The Double Helix Medals recognize individuals who have dedicated their lives to raising the awareness of the importance of genetics research for improving the health of people everywhere." Inaugurated in 2006, the medal is named for the iconic "winding-staircase" structure of the DNA molecule, discovered by Dr. Watson along with Dr. Francis Crick in 1953.

In 2007 Dr. Venter and his team published the first diploid genome, which was his genome and represents both sets of chromosomes inherited from each of his parents. That publication was the first human genome publication since the first sequence and analysis of the human genome published in Science in 2001 by Dr. Venter and colleagues at Celera Genomics. The publicly funded genome project also published their version of the human genome at the same time in the journal Nature.

Dr. Venter and his team are continuing to analyze his genome and are planning to sequence and analyze hundreds to thousands of genomes over the next decade. He has advocated the public release of individual genomes with the view that a growing database in which scientists can compare DNA profiles with health histories and traits will help them understand in greater detail the impact of genetics upon human health. Dr. Venter and his teams have published the sequences of more than 50 genomes, and through the Sorcerer II Expedition have more added more than 20 million new genes to the public databases.

Dr. Watson is Chancellor Emeritus of Cold Spring Harbor Laboratory and won a Nobel Prize along with Francis Crick in 1962 for their description of the structure of DNA. Dr. Watson is credited for developing the modern vision for Cold Spring Harbor Laboratory.

About the J. Craig Venter Institute

The JCVI is a not-for-profit research institute in Rockville, MD and La Jolla, CA dedicated to the advancement of the science of genomics; the understanding of its implications for society; and communication of those results to the scientific community, the public, and policymakers. Founded by J. Craig Venter, Ph.D., the JCVI is home to approximately 400 scientists and staff with expertise in human and evolutionary biology, genetics, bioinformatics/informatics, information technology, high-throughput DNA sequencing, genomic and environmental policy research, and public education in science and science policy. The legacy organizations of the JCVI are: The Institute for Genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), the Institute for Biological Energy Alternatives (IBEA), the Joint Technology Center (JTC), and the J. Craig Venter Science Foundation. The JCVI is a 501(c)(3) organization. For additional information, please visit http://www.JCVI.org.


'/>"/>
SOURCE J. Craig Venter Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
2. Dr. Peter Nash, Ph.D. Joins Mach One Corporation as Chief Scientist
3. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
4. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
5. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
6. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
9. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
10. CryoCor Receives FDA Approval for Right Atrial Flutter
11. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016  Guerbet announced today that it ... Supplier Horizon Award . One of 12 ... recognized for its support of Premier members through exceptional ... excellence, and commitment to lower costs. ... recognition of our outstanding customer service from Premier," says ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Surgical Procedure Volumes: Global Analysis (United States, China, Japan, ... report to their offering. ... tool for healthcare business planners, provides surgical procedure volume ... surgery trends with an in-depth analysis of growth drivers ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... rough waters, but it continues to present great opportunities ... featured companies for today: Intrexon Corp. (NYSE: ... ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... Learn more about these stocks and receive your complimentary ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):